Skip to main content

Category Archives: Juvederm®

A patient receives Juvederm aftercare tips to reduce swelling and lessen recovery time.
February 15, 2025

Juvederm Aftercare Tips: Do’s & Don’ts for Best Results and Faster Recovery

Congratulations! You’ve just refreshed your look and brought out your natural beauty with Juvederm. Now it’s time to protect your results.  While Juvederm offers instant volume and smoothness, proper aftercare is necessary for optimal, long-lasting results.   Juvederm, a popular dermal filler made from hyaluronic acid, can enhance your features, smooth wrinkles, and restore lost volume. […]

Read More
Beverly Hills dermatologists
December 27, 2022

8 Important Questions to Ask Your Dermatologists

Before you book an appointment with our friendly Beverly Hills dermatologists, make sure to check their credentials and ask these eight important questions at your first appointment. How Frequently Should I Exfoliate? Is There Anything You Would Recommend for My Skin Type? Do You Think Injectable Treatments Are a Good Idea? Are There Any Treatments […]

Read More
July 30, 2019

9 Ways to Combat Undereye Circles

As we get older, undereye circles are an extremely common occurrence among most people. This scenario is one that we all wish to correct, and is one of the main focal points of any skin care routine. However, the term “undereye circles” is often used as a catch-all phrase that is used to refer to […]

Read More
July 14, 2014

Voluma™ XC in Los Angeles

The aging process affects many aspects of our face, but one of the most noticeable changes is the loss of volume. Several injectable fillers, including others from Juvederm®, have been developed to replace lost volume in the skin and reduce the appearance of wrinkles, but no filler has before now been FDA-approved for use in […]

Read More

A link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided for informational purposes only. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.